Showing results (121-130 of 148) with videos related to
Sort By:
Pageof 15
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 2, 2005
Carboplatin plus gemcitabine in patients with inoperable or metastatic pancreatic cancer: a phase II multicenter study by the Hellenic Cooperative Oncology GroupN Xiros, P Papacostas, T Economopoulos, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 1998
A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group studyG Fountzilas, A Athanassiades, T Giannakakis, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1997
Paclitaxel by three-hour infusion and carboplatin in advanced carcinoma of nasopharynx and other sites of the head and neck. A phase II study conducted by the Hellenic Cooperative Oncology GroupG Fountzilas, D Skarlos, A Athanassiades, et al.The Pharmacogenomics Journal|September 25, 2013
Vascular endothelial growth factor polymorphisms and clinical outcome in patients with metastatic breast cancer treated with weekly docetaxelA K Koutras, V Kotoula, C Papadimitriou, et al.Lung Cancer (Amsterdam, Netherlands)|March 29, 2006
Mutations of the epidermal growth factor receptor tyrosine kinase domain and associations with clinicopathological features in non-small cell lung cancer patientsS Murray, E Timotheadou, H Linardou, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2002
Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer. A Hellenic Cooperative Oncology Group phase II studyG Fountzilas, D Tsavdaridis, A Kalogera-Fountzila, et al.Anticancer Research|January 25, 2008
Combination chemotherapy with paclitaxel and gemcitabine followed by concurrent chemoradiotherapy in non-operable localized non-small cell lung cancer. A hellenic cooperative oncology group (HeCOG) phase II studyP Kosmidis, G Fountzilas, S Baka, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 26, 2012
Zoledronic acid in patients with stage IIIA/B NSCLC: results of a randomized, phase III studyG V Scagliotti, P Kosmidis, F de Marinis, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2001
Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: a randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG)D V Skarlos, E Samantas, E Briassoulis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Phase III trial of modulation of cisplatin/fluorouracil chemotherapy by interferon alfa-2b in patients with recurrent or metastatic head and neck cancer. Head and Neck Interferon Cooperative Study GroupD Schrijvers, J Johnson, U Jiminez, et al.Pageof 15